Press release
Chinese Fibromyalgia Market Growth Analysis 2018 with Pivotal Players as Pfizer, GlaxoSmithKline, AstraZeneca, Roche, Astellas Pharma, etc. by 2022
Market Research Future
Chinese Fibromyalgia Market Scenario:
Fibromyalgia syndrome co-exists with other painful conditions, such as migraine and other types of headaches, temporomandibular joint disorders, irritable bowel syndrome (IBS), and interstitial cystitis. The treatment of fibromyalgia includes both targeted and symptomatic approach. Till date, there are only three FDA approved drugs for the fibromyalgia treatment, i.e., Lyrica (PFIZER), Cymbalta (Eli Lilly and Company), and Savella (Allergan plc). However, there are few other drugs prescribed by physicians to control the symptoms of fibromyalgia such as pain relievers, muscle relaxants, and traditional Chinese medicine. The Chinese fibromyalgia market is expected to grow at a CAGR of 18.7% during the forecast period 2017-2022.
Get Premium Sample copy at https://www.marketresearchfuture.com/sample_request/5630
Growing geriatric population, increasing cases of rheumatic diseases, growing awareness among the population, and rising incidences of traumatic stress and road accidents are the key factors driving the Chinese fibromyalgia market. According to a study published in the Arthritis Care & Research journal in 2017, fibromyalgia and related symptoms worsen the functional status of individuals with rheumatoid arthritis. Around 15%-30% of patients with rheumatic disorders have co-morbid fibromyalgia syndrome.
Key Players:
Pfizer
GlaxoSmithKline
AstraZeneca
Roche
Astellas Pharma
Eli Lilly and Company
Johnson & Johnson Services
SANOFI and others.
Regional Analysis
South Central China accounted for the major share of the market owing to the rising prevalence of fibromyalgia in this region. Rising cases of chronic rheumatic diseases are also capable of fuelling the fibromyalgia market in China. Prevalence of rheumatoid arthritis is around 0.35%, with the significantly higher rate in Northern China as compared to the Southern part.
Have Any Query, Ask to Expert at https://www.marketresearchfuture.com/enquiry/5630
The rising healthcare expenditure is also propelling the growth of the market. In China, the total expenditure on health per capita in 2014 was USD 731, as per the World Health Organization (WHO) in 2015. The health expenditure in China grew at a rate of 11.6% per year, suggested by a study published in BMC Health Services Research journal in 2017. This rate is much faster than the growth of the country’s economy, i.e., 9.9% per year.
Segment:
The Chinese fibromyalgia market is segmented on the basis of diagnosis, treatment, and end-user.
On the basis of the diagnosis, the market is classified into laboratory evaluation and presence of central sensitization.
On the basis of the treatment, the market is segmented into targeted treatment and symptomatic treatment.
On the basis of the end-users, the market is segmented into hospitals, clinics, diagnostic centers, and others.
Major TOC of Chinese Fibromyalgia Market Research Report- Forecast to 2022:
1 Report Prologue
2 Market Introduction
3 Research Methodology
4 Market Dynamics
5 Market Factor Analysis
6 Chinese Fibromyalgia Market, By Diagnosis
7 Global and China Fibromyalgia Market, By Treatment
8 Chinese Fibromyalgia Market, By End Users
9 Chinese Fibromyalgia Market, By Regions
10 Competitive landscape
11 Company Profiles
12 Conclusion
13 Appendix
Get Stunning Discount at https://www.marketresearchfuture.com/check-discount/5630
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chinese Fibromyalgia Market Growth Analysis 2018 with Pivotal Players as Pfizer, GlaxoSmithKline, AstraZeneca, Roche, Astellas Pharma, etc. by 2022 here
News-ID: 1160377 • Views: …
More Releases from Market Research Future
Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing You …
Hydrofluoric acid (HF) is a crucial chemical compound with a wide range of applications across various industries. Despite its hazardous nature, it plays an essential role in manufacturing processes, especially in the production of fluorine compounds. The global hydrofluoric acid market has been witnessing steady growth, driven by demand from end-user industries such as oil refining, pharmaceuticals, and electronics.
The Hydrodesulfurization Catalysts Market is projected to register a CAGR of over…
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reachi …
In recent years, the global market for palm methyl ester derivatives has witnessed significant growth, driven by various factors including environmental concerns, technological advancements, and the increasing demand for sustainable alternatives in various industries. Palm methyl ester derivatives, derived from palm oil, have emerged as versatile ingredients with applications spanning across sectors such as cosmetics, pharmaceuticals, lubricants, and more.
The Palm Methyl Ester Derivative Market Size was valued at USD 1.5…
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 20 …
The Asia-Pacific ceramic tiles market has been witnessing robust growth, driven by various factors such as increasing investments in residential and commercial construction, renovation activities, and the growing preference for aesthetically pleasing and durable flooring solutions. Countries like China, India, Japan, and South Korea have been leading the market growth, supported by strong manufacturing capabilities, technological advancements, and evolving consumer preferences.
Asia-Pacific Ceramic Tiles Market Size was valued at USD 141.2…
APAC Wallpaper Market to Register Highest CAGR Growth of 8% by 2032: Analysis by …
The APAC wallpaper market has witnessed significant growth in recent years, driven by factors such as rising disposable incomes, expanding construction activities, and growing awareness regarding interior decor. Countries like China, India, Japan, South Korea, and Australia have emerged as key contributors to the region's wallpaper market. Additionally, the increasing adoption of innovative wallpaper designs and patterns is fueling market growth further.
APAC Wallpaper Market Size was valued at USD 0.55…
More Releases for Chinese
CCHATTY: combining AI technology with Chinese learning content for online Chines …
According to the statistics released by the Confucius Institute Headquarters, Currently, there are about 100 million Chinese learners around the global. This number will hit 130 million by 2020. For instance, in South Korea, around 10 million people are studying Chinese; Russia and Finland have listed learning Chinese as examinable courses, either as a first foreign language or a second foreign language. Therefore, Chinese learning worldwide has become an incremental…
Chinese Influence on Global Infrastructure
"The Latest Research Report Chinese Influence on Global Infrastructure provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
About Chinese Influence Market
This report outlines and analyzes all infrastructure projects around the world in which Chinese companies including owners, financers, and contractors are involved.
Summary
Throughout the 21st century, China has been a world leader in expanding its infrastructure base, creating the worlds largest high-speed rail…
Chinese Investors Look Abroad
Beijing, China July 30, 2012 – An Outbound Investment Seminar hosted by Chance & Bridge Partners drew a large audience of investors, Chinese SMEs, and international partner law firms.
Many Chinese investors and companies are looking to diversify their holdings and enter new markets. This has led to an increase in cross-border investment, banking, consulting, and legal services for the Chinese clients. Many of these areas were addressed during the…
Introducing A New Chinese Reader to Enable Chinese Language Students to Master C …
Capturing Chinese presents a new advanced Chinese reader helping students master the literature of China's best authors. Allowing students to put down their dictionaries and instead curl up with a book of Chinese literature, Capturing Chinese is a must have for intermediate and advanced Chinese language students.
The new book, titled Capturing Chinese Stories: Prose and Poems by Revolutionary Authors, features five of the most influential authors in recent Chinese history…
Capturing Chinese Introduces New Chinese Textbook – Lu Xun’s ‘The New Year …
CHINA (April 2011) – To aid advanced and intermediate students who find difficulty in learning Chinese, Kevin Nadolny, founder of Capturing Chinese, has published another masterpiece of Lu Xun --- The New Year’s Sacrifice.
This new book is part of the Capturing Chinese series written by the Father of Modern Chinese Literature,Lu Xun. Every book is set in an inventive format to ease the painstaking process of mastering the Chinese…
Host1Plus enters Chinese market
London, United Kingdom, January 14, 2011 - Host1Plus, a London based international hosting company has started its operations in Chinese market. The services will be managed from Singapore.
Host1Plus has contracted with one of the best data centers in Singapore. This deal allows Host1Plus providing the locally bases services in main language of China. The Chinese support will operate 24/7. The Chinese version of the website is http://cn.host1plus.com in Chinese Simplified…
